24 results
Thumbnail

D2.134 - Transitioning adolescents and young adults with asthma: insights from a severe asthma series

Thumbnail

D2.133 - Clinical and Direct Medical Burden of Hospitalized Children with Asthma Exacerbations

Thumbnail

D2.135 - What are our children breathing? Tracking exposure to air pollution during a school day

Thumbnail

D2.136 - Nasal transcriptomics as a biomarker for ICS/LABA treatment in paediatric asthma in the PUFFIN study

Thumbnail

D2.137 - Long term, Persistent Eosinophilia in patients with Asthma and CRSwNP undergoing Dupilumab therapy: preliminar results of a 24-month follow up prospective study

Thumbnail

D2.138 - The Effect of Human Milk Oligosaccharides 2’FL and 3FL on Macrophage polarization

Thumbnail

D2.139 - Oxidative stress and tissue hypoxia are triggered through the increased respiratory effort during sleep and reflect the inflammation as a stress link in the gut-brain axis in children suffering asthma, allergic/non-allergic rhinitis, and/or eczema

Thumbnail

D2.140 - Allergic Sensitization Patterns in Western Romania: Impact of Airborne Allergens and Climate Factors

Thumbnail

D2.142 - Smoking cessation advice to parents in children with bronchial asthma- still it is a long way to go

Thumbnail

D2.144 - Occupational Asthma due to garlic powder: a case report

Thumbnail

D2.145 - The utility of blood eosinophils, IgE and skin prick testing in paediatric asthma diagnosis

Thumbnail

D2.146 - Occupational Asthma due to Subtilisin: the power of specific inhalation challenge

Thumbnail

D2.147 - Comparison of clinical outcomes with Benralizumab in severe eosinophilic asthma: Switched and naïve patients

Thumbnail

D3.419 - Prevalence of physical urticaria hives in patients with systemic mastocytosis and their relation to disease course – preliminary data

Thumbnail

D3.411 - Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases

Thumbnail

D3.412 - MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin

Thumbnail

D3.413 - Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis (NonAdvSM) Patients and Establishing Content Validity

Thumbnail

D3.414 - The Phase 2/3 Study of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis

Thumbnail

D3.415 - Clinical manifestations of Hereditary alpha-tryptasemia (HaT) in Patients with Mast Cell Activation Syndromes

Thumbnail

D3.416 - Hereditary Alpha-Tryptasemia: A Case Series